SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Weissman Kenneth Ian

(Last) (First) (Middle)
902 BROADWAY
20TH FLOOR

(Street)
NEW YORK NY 10010-6002

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Sr VP & Corporate Secretary
3. Date of Earliest Transaction (Month/Day/Year)
03/07/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
common shares (opening balance) 5,688 D
common shares 03/07/2019 M 706(1) A $0.00 6,394 D
common shares 03/07/2019 M 722(1) A $0.00 7,116 D
common shares 03/07/2019 M 1,439(1) A $0.00 8,555 D
common shares 03/08/2019 S 1,129(2) D $22.4313 7,426 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
restricted share units(3) $0.00(4) 03/07/2019 M 706(1) (5) (5) common shares 706 $0.00(4) 848(6) D
restricted share units(3) $0.00(4) 03/07/2019 M 722(1) (5) (5) common shares 722 $0.00(4) 1,589(6) D
restricted share units(3) $0.00(4) 03/07/2019 M 1,439(1) (5) (5) common shares 1,439 $0.00(4) 5,755(6) D
stock options (to buy) $22.49 03/07/2019 A 7,072 (7) 03/07/2026 common shares 7,072 $22.49 7,072(6) D
restricted share units(3) $0.00(4) 03/07/2019 A 6,669 (8) (8) common shares 6,669 $0.00(4) 6,669(6) D
Explanation of Responses:
1. Represents the conversion upon vesting of restricted share units into common shares.
2. Mr. Weissman is reporting the sale of common shares to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit
3. Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
4. Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.
5. The restricted share units vest and will be converted to common shares in four installments: 20% of the initial grant on the first anniversary of the grant date, 25% of the initial grant on each of the second and third anniversaries of the grant date and 30% of the initial grant on December 1 of the third year after the grant date.
6. This represents the number of restricted share units or stock options for this transaction only. Mr. Weissman's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 33,503; 14,861 and 7,426 respectively.
7. The stock options will become exercisable in 4 installments: 1,414 on March 7, 2020; 1,768 on each of March 7, 2021 and March 7, 2022 and 2,122 on March 7, 2023.
8. The restricted share units vest and will be converted to common shares in four installments 1,333 on March 7, 2020; 1,667 on each of March 7, 2021 and March 7, 2022 and 2,022 on December 1, 2022.
Remarks:
Kenneth Weissman 03/08/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.